Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,430 | -13,448 | -93,063 | -62,656 | -25,606 |
| Depreciation Amortization | 2 | 1 | 2 | 2 | 1 |
| Accounts receivable | N/A | N/A | 831 | 831 | 831 |
| Other Working Capital | -2,209 | 3,991 | -4,898 | -3,960 | -2,560 |
| Other Operating Activity | -2,534 | -924 | 59,425 | 39,360 | 12,925 |
| Operating Cash Flow | $-25,171 | $-10,380 | $-37,703 | $-26,423 | $-14,409 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6 | -3 | -7 | -7 | -3 |
| Investing Cash Flow | $-6 | $-3 | $-7 | $-7 | $-3 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -518 | N/A | -176 | -177 | N/A |
| Common Stock Issued | 22,638 | 22,980 | 53,682 | 53,682 | 15,989 |
| Other Financing Activity | 0 | 0 | 9,950 | 9,950 | 9,950 |
| Financing Cash Flow | $22,120 | $22,980 | $63,456 | $63,455 | $25,939 |
| Beginning Cash Position | 27,605 | 27,605 | 1,859 | 1,859 | 1,859 |
| End Cash Position | 24,548 | 40,202 | 27,605 | 38,884 | 13,386 |
| Net Cash Flow | $-3,057 | $12,597 | $25,746 | $37,025 | $11,527 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,171 | -10,380 | -37,703 | -26,423 | -14,409 |
| Capital Expenditure | -6 | -3 | -7 | -7 | -3 |
| Free Cash Flow | -25,177 | -10,383 | -37,710 | -26,430 | -14,412 |